University of California San Francisco
Give to UCSF
Thirty-two UCSF scientists are among the most influential individuals in their respective fields, according to the most recent analysis of research citations by the science and intellectual property company, Clarivate.
UCSF researchers found that regular screening is not always sufficient to prevent an advanced breast cancer diagnosis.
In 2024, UCSF Health will celebrate 35 years of performing heart transplants. Since completing their first heart transplant in March 1989, UCSF surgeons have performed nearly 600 and, along the way,
The UC San Francisco School of Dentistry has received a $4 million National Institutes of Health (NIH) grant to kickstart its clinical research program, in part by developing a new artificial
Personalized health and lifestyle changes such as increased exercise and socializtion can delay or even prevent memory loss for higher-risk older adults.
A previously unknown signaling cycle stemming from our sense of taste helps suppress our appetites.
Breast cancer was the second most commonly diagnosed cancer in women, after skin cancer – accounting for 31% of all new female cancer diagnoses in 2022. Yet, determining who is most at risk of breast
Researchers offer a theory for why many people experience headaches as soon as 30 minutes after drinking red wine.
University of California prostate cancer experts will share clinical insights at the first annual PSMA Conference, “PSMA PET and RLT: Present and Future.” The conference will take place online and in
The COVID-19 pandemic slowed previous gains made in controlling HIV blood levels and worsened health disparities.
A gene expression test can accurately predict the best treatment for meningioma patients by measuring the aggressiveness of their tumors and adjusting treatment accordingly.
It’s been known for many years that people who smoke tobacco have poor blood vessel function. Now, a team of researchers at UC San Francisco has shown that people who smoke marijuana have the same
New research shows that in the U.S., the longevity gap between women and men has been widening for more than a decade, with women outliving men by an average of six years.
Multiple sclerosis patients whose blood tests reveal elevated NfL, a biomarker of nerve damage, could see worsening disability one to two years later.
A bad night of sleep was associated with a 15% greater risk of having an atrial fibrillation (A-Fib) episode the following day, along with conditions like blood clots, heart failure, stroke and other heart-related problems.
A collaboration is between two biomedical researchers bridges the laboratory and clinic to advance the science of itch, allergy and asthma.
A phase 1 trial shows promise in treating metastatic prostate cancer with a single priming dose of radioligand therapy and immunotherapy.
Laura Esserman discusses breast cancer risk factors, progress in the field and the importance of tailoring treatment for women with low-risk cancer while also identifying women at high risk of invasive cancer.
UCSF's Adam Boxer, MD, PhD, and Harvard neurologist Reisa Sperling, MD, review the history of clinical trials over the past 30 years in Alzheimer’s research with what was learned and how new biomarkers and clinical trial approaches are being used to find more effective treatments in a more efficient way than in the past.
UCSF researchers developed a new neighborhood-based model of care that brings medicine to people immediately after being diagnosed with hepatitis C.
A UCSF-led found that people who are experiencing homelessness have a 16-fold higher rate of sudden death from heart attacks, as well as other causes.
